2017
DOI: 10.1038/ncomms16081
|View full text |Cite|
|
Sign up to set email alerts
|

Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening

Abstract: The identification and prioritization of chemically tractable therapeutic targets is a significant challenge in the discovery of new medicines. We have developed a novel method that rapidly screens multiple proteins in parallel using DNA-encoded library technology (ELT). Initial efforts were focused on the efficient discovery of antibacterial leads against 119 targets from Acinetobacter baumannii and Staphylococcus aureus. The success of this effort led to the hypothesis that the relative number of ELT binders… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
46
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(47 citation statements)
references
References 56 publications
0
46
0
Order By: Relevance
“…A key consideration, therefore, was the contribution of the photoreactive warhead to the binding affinity. Analogues of hit PhABits were synthesised with acetyl-and butanoyl-amides in place of the photoreactive group to explore the impact this had on potency (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)Supplementary Figure 3). A decrease of less than 0.6 log units in the TR-FRET assay was observed upon truncating to the acetylamide analogues, and potency was typically recovered in the butanoylamide analogues ( Figure 2C).…”
Section: Promiscuity and Non-specific Crosslinkingmentioning
confidence: 99%
See 1 more Smart Citation
“…A key consideration, therefore, was the contribution of the photoreactive warhead to the binding affinity. Analogues of hit PhABits were synthesised with acetyl-and butanoyl-amides in place of the photoreactive group to explore the impact this had on potency (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)Supplementary Figure 3). A decrease of less than 0.6 log units in the TR-FRET assay was observed upon truncating to the acetylamide analogues, and potency was typically recovered in the butanoylamide analogues ( Figure 2C).…”
Section: Promiscuity and Non-specific Crosslinkingmentioning
confidence: 99%
“…6 Bindingdriven assays, such as Affinity Selection Mass Spectrometry (ASMS) and DNA Encoded Libraries (DELs) have recently been developed to accelerate ligand discovery through the efficient screening of large libraries (10 6 -10 12 compounds). [7][8][9][10][11][12][13][14][15][16] While these approaches are powerful, they employ lead-like libraries (MW>300) that generate hits that may suffer from sub-optimal ligand efficiency and can prove challenging to optimise. Additionally, the upfront investment in library generation, and sample handling, limits the accessibility of this screening strategy to the broader scientific community.…”
Section: Introductionmentioning
confidence: 99%
“…Both α-substituted (18-24) and β-substituted (26,27) acceptors could be employed in this protocol, providing the Giese products in excellent yields. Reactive functional groups such as aldehydes (18) and acids (19,20) were tolerated in this coupling, allowing them to serve as handles for a variety of DEL-compatible downstream functionalizations (e.g., reductive amination or amide-bond formation, respectively). Moreover, acrylates with a CH 2 SO 2 Tol in the α-position underwent elimination following radical addition (58), leading to another Michael acceptor moiety (25) and making the process amenable for iterative multicycle C-C bond forming Giese in a DEL context.…”
Section: Significancementioning
confidence: 99%
“…In this way, libraries of incredible size (up to >10 9 members) could be procured and screened at once (rather than one by one in traditional combinatorial chemistry) with the ultimate vision of democratizing the practice of medicinal chemistry (10)(11)(12)(13)(14)(15). The vision and principles outlined therein are only recently being realized with advances in analysis and chemoselective synthesis, setting the stage for the widespread adoption of DEL-based discovery platforms in the pharmaceutical arena (16)(17)(18)(19)(20). DNA-compatible synthesis provides exciting challenges (21)(22)(23), particularly as most traditional techniques are not amenable to the idiosyncratic requirements of such systems (24,25).…”
mentioning
confidence: 99%
“…Since the seminal paper by Clark et al 1 that saw the concept of DNA encoded libraries (DELs) reduced to practice, the technology has been gaining popularity as a novel hit discovery [2][3][4] and, more recently, target prioritization tool. 5 DELs represent large combinatorial libraries of small molecules that are typically generated using a split-and-pool methodology, with 3 to 4 cycles of chemistry providing routine access to millions or even billions of unique compounds. Unlike traditional chemical libraries, though, each compound in a DEL is attached to a sequence of DNA -the tag or barcode -that stores information on its complete synthetic history, and all DEL members are kept in a mixture.…”
Section: Introductionmentioning
confidence: 99%